Annual General Meeting in Cessatech A/S

13. November, 2025

The Company has advanced well with its planned activities Closing the clinical and regulatory...

31. October, 2025

Successful completion of technology transfer of CT001 with STAQ Pharma supporting near term product...

21. August, 2025

The Company has advanced well with its planned activities Positive and clinical meaningful top-line...

Related articles